Loading…

Carbocyclic Analogues of the Potent Cytidine Deaminase Inhibitor 1-(β-d-Ribofuranosyl)-1,2-dihydropyrimidin-2-one (Zebularine)

Three carbocylic analogues of the potent cytidine deaminase inhibitor (CDA) zebularine [1-(β-d-ribofuranosyl)-1,2-dihydropyrimidin-2-one, 1a] were synthesized. The selected pseudosugar templates correspond, respectively, to the cyclopentenyl moiety of neplanocin A (compound 4), the cyclopentyl moiet...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 1998-07, Vol.41 (14), p.2572-2578
Main Authors: Jeong, Lak Shin, Buenger, Greg, McCormack, John J, Cooney, David A, Hao, Zhang, Marquez, Victor E
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a408t-852bb502ea3b0eacd79ddb1abc907de0fe14e7af09719d776821916ac9468a9d3
cites cdi_FETCH-LOGICAL-a408t-852bb502ea3b0eacd79ddb1abc907de0fe14e7af09719d776821916ac9468a9d3
container_end_page 2578
container_issue 14
container_start_page 2572
container_title Journal of medicinal chemistry
container_volume 41
creator Jeong, Lak Shin
Buenger, Greg
McCormack, John J
Cooney, David A
Hao, Zhang
Marquez, Victor E
description Three carbocylic analogues of the potent cytidine deaminase inhibitor (CDA) zebularine [1-(β-d-ribofuranosyl)-1,2-dihydropyrimidin-2-one, 1a] were synthesized. The selected pseudosugar templates correspond, respectively, to the cyclopentenyl moiety of neplanocin A (compound 4), the cyclopentyl moiety of aristeromycin (compound 5), and a newly designed, rigid bicyclo[3.1.0]hexane moiety (compound 6). These three carba-nucleoside versions of zebularine were fashioned to overcome the inherent instability of the parent drug. Each target compound was approached differently using either convergent or linear approaches. The immediate precursor to the cyclopentenyl analogue 4 was obtained by a Mitsunobu coupling of pseudosugar 7 with 2-hydroxypyrimidine. The cyclopentyl analogue 5 was linearly constructed from carbocyclic amine 17, and the final target 6 was similarly constructed from the carbobicyclic amine 27. Of the three target compounds, only 5 showed a significant level of inhibition against human CDA, but it was 16 times less potent than zebularine (K i = 38 μM vs K i(apparent) = 2.3 μM). Although these carbocyclic analogues appeared to be more stable than zebularine, replacement of the electronegative CO4‘ oxygen for the less electronegative carbon in 4−6 presumably reduces the capacity of the pyrimidin-2(1H)-one ring to form a covalent hydrate, a step considered crucial for the compound to function as a transition-state inhibitor of the enzyme.
doi_str_mv 10.1021/jm980111x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79986515</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17411091</sourcerecordid><originalsourceid>FETCH-LOGICAL-a408t-852bb502ea3b0eacd79ddb1abc907de0fe14e7af09719d776821916ac9468a9d3</originalsourceid><addsrcrecordid>eNqFkctu1DAUhiMEKkNhwQMgZQGoI2HwcS6Ol9UU2qJKVKVs2FjHlzAekniwE6lZ9Z14EJ4JVzOaFRKrs_g_fTrn_Fn2Euh7oAw-bHrRUAC4e5QtoGKUlA0tH2cLShkjrGbF0-xZjBtKaQGsOMqORF0B1LDI7lcYlNez7pzOTwfs_I_Jxty3-bi2-bUf7TDmq3l0xg02P7PYuwGjzS-HtVNu9CEHcvLnNzHkxinfTgEHH-duSeAdI8atZxP8dg6ufxAQRnyynHy3auowJOPyefakxS7aF_t5nH379PF2dUGuvpxfrk6vCJa0GUlTMaUqyiwWilrUhgtjFKDSgnJjaWuhtBxbKjgIw3ndMBBQoxZl3aAwxXH2dufdBv8rXTjK3kVtuw4H66couRBN-kn1XxB4CUAFJHC5A3XwMQbbym06E8MsgcqHVuShlcS-2ksn1VtzIPc1pPz1PseosWvTF7WLB4wVrCwZSxjZYS6O9u4QY_gpa17wSt5ef5Xi_DMUNxdC0sS_2fGoo9z4KaR-4z_W-wtx3a_z</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17411091</pqid></control><display><type>article</type><title>Carbocyclic Analogues of the Potent Cytidine Deaminase Inhibitor 1-(β-d-Ribofuranosyl)-1,2-dihydropyrimidin-2-one (Zebularine)</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Jeong, Lak Shin ; Buenger, Greg ; McCormack, John J ; Cooney, David A ; Hao, Zhang ; Marquez, Victor E</creator><creatorcontrib>Jeong, Lak Shin ; Buenger, Greg ; McCormack, John J ; Cooney, David A ; Hao, Zhang ; Marquez, Victor E</creatorcontrib><description>Three carbocylic analogues of the potent cytidine deaminase inhibitor (CDA) zebularine [1-(β-d-ribofuranosyl)-1,2-dihydropyrimidin-2-one, 1a] were synthesized. The selected pseudosugar templates correspond, respectively, to the cyclopentenyl moiety of neplanocin A (compound 4), the cyclopentyl moiety of aristeromycin (compound 5), and a newly designed, rigid bicyclo[3.1.0]hexane moiety (compound 6). These three carba-nucleoside versions of zebularine were fashioned to overcome the inherent instability of the parent drug. Each target compound was approached differently using either convergent or linear approaches. The immediate precursor to the cyclopentenyl analogue 4 was obtained by a Mitsunobu coupling of pseudosugar 7 with 2-hydroxypyrimidine. The cyclopentyl analogue 5 was linearly constructed from carbocyclic amine 17, and the final target 6 was similarly constructed from the carbobicyclic amine 27. Of the three target compounds, only 5 showed a significant level of inhibition against human CDA, but it was 16 times less potent than zebularine (K i = 38 μM vs K i(apparent) = 2.3 μM). Although these carbocyclic analogues appeared to be more stable than zebularine, replacement of the electronegative CO4‘ oxygen for the less electronegative carbon in 4−6 presumably reduces the capacity of the pyrimidin-2(1H)-one ring to form a covalent hydrate, a step considered crucial for the compound to function as a transition-state inhibitor of the enzyme.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm980111x</identifier><identifier>PMID: 9651161</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Analytical, structural and metabolic biochemistry ; Animals ; aristeromycin ; Biological and medical sciences ; Cytidine - analogs &amp; derivatives ; cytidine deaminase ; Cytidine Deaminase - antagonists &amp; inhibitors ; Enzyme Inhibitors - chemical synthesis ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - pharmacology ; Enzymes and enzyme inhibitors ; Fundamental and applied biological sciences. Psychology ; Humans ; Hydrolases ; Mice ; Pyrimidine Nucleosides - chemical synthesis ; Pyrimidine Nucleosides - chemistry ; Pyrimidine Nucleosides - pharmacology ; Structure-Activity Relationship ; zebularine</subject><ispartof>Journal of medicinal chemistry, 1998-07, Vol.41 (14), p.2572-2578</ispartof><rights>Copyright © 1998 American Chemical Society</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a408t-852bb502ea3b0eacd79ddb1abc907de0fe14e7af09719d776821916ac9468a9d3</citedby><cites>FETCH-LOGICAL-a408t-852bb502ea3b0eacd79ddb1abc907de0fe14e7af09719d776821916ac9468a9d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2324422$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9651161$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jeong, Lak Shin</creatorcontrib><creatorcontrib>Buenger, Greg</creatorcontrib><creatorcontrib>McCormack, John J</creatorcontrib><creatorcontrib>Cooney, David A</creatorcontrib><creatorcontrib>Hao, Zhang</creatorcontrib><creatorcontrib>Marquez, Victor E</creatorcontrib><title>Carbocyclic Analogues of the Potent Cytidine Deaminase Inhibitor 1-(β-d-Ribofuranosyl)-1,2-dihydropyrimidin-2-one (Zebularine)</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Three carbocylic analogues of the potent cytidine deaminase inhibitor (CDA) zebularine [1-(β-d-ribofuranosyl)-1,2-dihydropyrimidin-2-one, 1a] were synthesized. The selected pseudosugar templates correspond, respectively, to the cyclopentenyl moiety of neplanocin A (compound 4), the cyclopentyl moiety of aristeromycin (compound 5), and a newly designed, rigid bicyclo[3.1.0]hexane moiety (compound 6). These three carba-nucleoside versions of zebularine were fashioned to overcome the inherent instability of the parent drug. Each target compound was approached differently using either convergent or linear approaches. The immediate precursor to the cyclopentenyl analogue 4 was obtained by a Mitsunobu coupling of pseudosugar 7 with 2-hydroxypyrimidine. The cyclopentyl analogue 5 was linearly constructed from carbocyclic amine 17, and the final target 6 was similarly constructed from the carbobicyclic amine 27. Of the three target compounds, only 5 showed a significant level of inhibition against human CDA, but it was 16 times less potent than zebularine (K i = 38 μM vs K i(apparent) = 2.3 μM). Although these carbocyclic analogues appeared to be more stable than zebularine, replacement of the electronegative CO4‘ oxygen for the less electronegative carbon in 4−6 presumably reduces the capacity of the pyrimidin-2(1H)-one ring to form a covalent hydrate, a step considered crucial for the compound to function as a transition-state inhibitor of the enzyme.</description><subject>Analytical, structural and metabolic biochemistry</subject><subject>Animals</subject><subject>aristeromycin</subject><subject>Biological and medical sciences</subject><subject>Cytidine - analogs &amp; derivatives</subject><subject>cytidine deaminase</subject><subject>Cytidine Deaminase - antagonists &amp; inhibitors</subject><subject>Enzyme Inhibitors - chemical synthesis</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Enzymes and enzyme inhibitors</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Hydrolases</subject><subject>Mice</subject><subject>Pyrimidine Nucleosides - chemical synthesis</subject><subject>Pyrimidine Nucleosides - chemistry</subject><subject>Pyrimidine Nucleosides - pharmacology</subject><subject>Structure-Activity Relationship</subject><subject>zebularine</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkctu1DAUhiMEKkNhwQMgZQGoI2HwcS6Ol9UU2qJKVKVs2FjHlzAekniwE6lZ9Z14EJ4JVzOaFRKrs_g_fTrn_Fn2Euh7oAw-bHrRUAC4e5QtoGKUlA0tH2cLShkjrGbF0-xZjBtKaQGsOMqORF0B1LDI7lcYlNez7pzOTwfs_I_Jxty3-bi2-bUf7TDmq3l0xg02P7PYuwGjzS-HtVNu9CEHcvLnNzHkxinfTgEHH-duSeAdI8atZxP8dg6ufxAQRnyynHy3auowJOPyefakxS7aF_t5nH379PF2dUGuvpxfrk6vCJa0GUlTMaUqyiwWilrUhgtjFKDSgnJjaWuhtBxbKjgIw3ndMBBQoxZl3aAwxXH2dufdBv8rXTjK3kVtuw4H66couRBN-kn1XxB4CUAFJHC5A3XwMQbbym06E8MsgcqHVuShlcS-2ksn1VtzIPc1pPz1PseosWvTF7WLB4wVrCwZSxjZYS6O9u4QY_gpa17wSt5ef5Xi_DMUNxdC0sS_2fGoo9z4KaR-4z_W-wtx3a_z</recordid><startdate>19980702</startdate><enddate>19980702</enddate><creator>Jeong, Lak Shin</creator><creator>Buenger, Greg</creator><creator>McCormack, John J</creator><creator>Cooney, David A</creator><creator>Hao, Zhang</creator><creator>Marquez, Victor E</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7X8</scope></search><sort><creationdate>19980702</creationdate><title>Carbocyclic Analogues of the Potent Cytidine Deaminase Inhibitor 1-(β-d-Ribofuranosyl)-1,2-dihydropyrimidin-2-one (Zebularine)</title><author>Jeong, Lak Shin ; Buenger, Greg ; McCormack, John J ; Cooney, David A ; Hao, Zhang ; Marquez, Victor E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a408t-852bb502ea3b0eacd79ddb1abc907de0fe14e7af09719d776821916ac9468a9d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Analytical, structural and metabolic biochemistry</topic><topic>Animals</topic><topic>aristeromycin</topic><topic>Biological and medical sciences</topic><topic>Cytidine - analogs &amp; derivatives</topic><topic>cytidine deaminase</topic><topic>Cytidine Deaminase - antagonists &amp; inhibitors</topic><topic>Enzyme Inhibitors - chemical synthesis</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Enzymes and enzyme inhibitors</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Hydrolases</topic><topic>Mice</topic><topic>Pyrimidine Nucleosides - chemical synthesis</topic><topic>Pyrimidine Nucleosides - chemistry</topic><topic>Pyrimidine Nucleosides - pharmacology</topic><topic>Structure-Activity Relationship</topic><topic>zebularine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jeong, Lak Shin</creatorcontrib><creatorcontrib>Buenger, Greg</creatorcontrib><creatorcontrib>McCormack, John J</creatorcontrib><creatorcontrib>Cooney, David A</creatorcontrib><creatorcontrib>Hao, Zhang</creatorcontrib><creatorcontrib>Marquez, Victor E</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jeong, Lak Shin</au><au>Buenger, Greg</au><au>McCormack, John J</au><au>Cooney, David A</au><au>Hao, Zhang</au><au>Marquez, Victor E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carbocyclic Analogues of the Potent Cytidine Deaminase Inhibitor 1-(β-d-Ribofuranosyl)-1,2-dihydropyrimidin-2-one (Zebularine)</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1998-07-02</date><risdate>1998</risdate><volume>41</volume><issue>14</issue><spage>2572</spage><epage>2578</epage><pages>2572-2578</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Three carbocylic analogues of the potent cytidine deaminase inhibitor (CDA) zebularine [1-(β-d-ribofuranosyl)-1,2-dihydropyrimidin-2-one, 1a] were synthesized. The selected pseudosugar templates correspond, respectively, to the cyclopentenyl moiety of neplanocin A (compound 4), the cyclopentyl moiety of aristeromycin (compound 5), and a newly designed, rigid bicyclo[3.1.0]hexane moiety (compound 6). These three carba-nucleoside versions of zebularine were fashioned to overcome the inherent instability of the parent drug. Each target compound was approached differently using either convergent or linear approaches. The immediate precursor to the cyclopentenyl analogue 4 was obtained by a Mitsunobu coupling of pseudosugar 7 with 2-hydroxypyrimidine. The cyclopentyl analogue 5 was linearly constructed from carbocyclic amine 17, and the final target 6 was similarly constructed from the carbobicyclic amine 27. Of the three target compounds, only 5 showed a significant level of inhibition against human CDA, but it was 16 times less potent than zebularine (K i = 38 μM vs K i(apparent) = 2.3 μM). Although these carbocyclic analogues appeared to be more stable than zebularine, replacement of the electronegative CO4‘ oxygen for the less electronegative carbon in 4−6 presumably reduces the capacity of the pyrimidin-2(1H)-one ring to form a covalent hydrate, a step considered crucial for the compound to function as a transition-state inhibitor of the enzyme.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>9651161</pmid><doi>10.1021/jm980111x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1998-07, Vol.41 (14), p.2572-2578
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_79986515
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Analytical, structural and metabolic biochemistry
Animals
aristeromycin
Biological and medical sciences
Cytidine - analogs & derivatives
cytidine deaminase
Cytidine Deaminase - antagonists & inhibitors
Enzyme Inhibitors - chemical synthesis
Enzyme Inhibitors - chemistry
Enzyme Inhibitors - pharmacology
Enzymes and enzyme inhibitors
Fundamental and applied biological sciences. Psychology
Humans
Hydrolases
Mice
Pyrimidine Nucleosides - chemical synthesis
Pyrimidine Nucleosides - chemistry
Pyrimidine Nucleosides - pharmacology
Structure-Activity Relationship
zebularine
title Carbocyclic Analogues of the Potent Cytidine Deaminase Inhibitor 1-(β-d-Ribofuranosyl)-1,2-dihydropyrimidin-2-one (Zebularine)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T03%3A43%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carbocyclic%20Analogues%20of%20the%20Potent%20Cytidine%20Deaminase%20Inhibitor%201-(%CE%B2-d-Ribofuranosyl)-1,2-dihydropyrimidin-2-one%20(Zebularine)&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Jeong,%20Lak%20Shin&rft.date=1998-07-02&rft.volume=41&rft.issue=14&rft.spage=2572&rft.epage=2578&rft.pages=2572-2578&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm980111x&rft_dat=%3Cproquest_cross%3E17411091%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a408t-852bb502ea3b0eacd79ddb1abc907de0fe14e7af09719d776821916ac9468a9d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17411091&rft_id=info:pmid/9651161&rfr_iscdi=true